Role of the BBB in HIV brain infection during methamphetamine abuse
BBB 在甲基苯丙胺滥用期间 HIV 脑部感染中的作用
基本信息
- 批准号:9249014
- 负责人:
- 金额:$ 38.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-01 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdultBehavior TherapyBiologicalBloodBlood - brain barrier anatomyBrainBrain PathologyCellsClinicDevelopmentDrug abuseEndotheliumEnvironmentEventExerciseExposure toFunctional disorderHIVHIV InfectionsHIV Long Terminal RepeatHIV tat ProteinHIV-1HemorrhageHomeostasisImpaired cognitionImpairmentInfectionKnowledgeLaboratoriesLeadLinkMaintenanceMediatingMethamphetamineNeurocognitiveNeurocognitive DeficitNeurodegenerative DisordersNeuronsOutcomePharmacologyPhysical activityPlayPropertyProteinsResearchRisk FactorsRoleStem cellsStreamStructureTherapeuticTight JunctionsToxic effectbasebrain endothelial cellcerebrovascularcognitive developmentinnovationmethamphetamine abusemethamphetamine exposurenerve stem cellneurogenesisneurotoxicitynew therapeutic targetnovelnovel therapeutic interventionoccludinpathogenpreventprogenitorprotective effectpublic health relevancetranscription factortranslational approach
项目摘要
DESCRIPTION (provided by applicant): The blood-brain barrier (BBB) is the most prominent barrier of the CNS and represents the essential interface between the CNS and the blood stream. The intact BBB is maintained by tight junction (TJ) proteins and is a paramount determinant of brain homeostasis. Disruption of the BBB is frequently observed during drug abuse and brain infections by various pathogens, including HIV. Our critically important results indicate that occludin, one of the major TJ proteins, is decreased upon methamphetamine (METH) exposure and that diminished occludin levels not only lead to the loss of integrity of the BBB but also stimulate HIV replication. The proposed research is built on these exciting findings by its focus on the central hypothesis that cerebrovascular alterations at the BBB level induced by METH have profound impact on establishing and outcome of the brain infection by HIV. Guided by the preliminary findings, this application offers a unique perspective on the interactions between METH and HIV via targeting the BBB. In Aim 1, we will evaluate the impact of METH-induced decrease in occludin expression on activation of NF-¿B and SP-1, enhancing interactions of this transcription factors with the HIV long-terminal repeats (LTRs) and thus stimulating HIV replication. In Aim 2, we will study the impact of METH and HIV-induced disruption of BBB on aberrant neurogenesis of neural progenitor cells resulting in the development of cognitive dysfunction. Aim 3 will focus on behavioral intervention based on exercise for protection against METH and HIV-induced BBB dysfunction and neurocognitive alterations. The proposed research is highly innovative and is likely to lead to the development of new translational knowledge for the clinic and identification of new regulatory mechanisms of HIV replication. The completion of this application has the potential to change our understanding of the cellular role of occludin in HIV infection and the role of the BBB in the development of METH and/or HIV-associated cognitive dysfunction. Furthermore, the expected results are likely to be also relevant to other neurodegenerative diseases that have significant cerebrovascular components.
描述(由申请人提供):血脑屏障(BBB)是CNS最重要的屏障,代表CNS和血流之间的重要界面。完整的BBB由紧密连接(TJ)蛋白维持,并且是脑稳态的最重要决定因素。在药物滥用和各种病原体(包括艾滋病毒)的脑感染期间经常观察到血脑屏障的破坏。我们至关重要的结果表明,闭合蛋白,一个主要的TJ蛋白,减少甲基苯丙胺(METH)曝光后,闭合蛋白水平的降低不仅导致BBB的完整性的损失,但也刺激HIV复制。拟议的研究是建立在这些令人兴奋的发现的基础上,其重点是中心假设,即METH诱导的BBB水平的脑血管改变对HIV脑感染的建立和结果具有深远的影响。在初步研究结果的指导下,该应用提供了一个独特的视角,通过靶向血脑屏障,了解METH与HIV之间的相互作用。在目标1中,我们将评估MET诱导的闭合蛋白表达减少对NF-B和SP-1活化的影响,增强这种转录因子与HIV长末端重复序列(LTR)的相互作用,从而刺激HIV复制。在目标2中,我们将研究METH和HIV诱导的BBB破坏对神经祖细胞异常神经发生的影响,从而导致认知功能障碍的发展。目标3将侧重于基于运动的行为干预,以防止METH和HIV诱导的BBB功能障碍和神经认知改变。拟议的研究是高度创新的,可能会导致新的翻译知识的临床和识别艾滋病毒复制的新的调节机制的发展。该应用的完成有可能改变我们对occludin在HIV感染中的细胞作用以及BBB在METH和/或HIV相关认知功能障碍发展中的作用的理解。此外,预期结果可能也与其他具有显著脑血管成分的神经退行性疾病相关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michal Toborek其他文献
Michal Toborek的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michal Toborek', 18)}}的其他基金
Defining brain pericytes as a novel and myeloid-derived HIV reservoir
将大脑周细胞定义为一种新型的、源自骨髓的 HIV 储存库
- 批准号:
10432128 - 财政年份:2021
- 资助金额:
$ 38.38万 - 项目类别:
Defining brain pericytes as a novel and myeloid-derived HIV reservoir
将大脑周细胞定义为一种新型的、源自骨髓的 HIV 储存库
- 批准号:
10327440 - 财政年份:2021
- 资助金额:
$ 38.38万 - 项目类别:
Defining brain pericytes as a novel and myeloid-derived HIV reservoir
将大脑周细胞定义为一种新型的、源自骨髓的 HIV 储存库
- 批准号:
10612454 - 财政年份:2021
- 资助金额:
$ 38.38万 - 项目类别:
Targeting Inflammasomes in Substance Abuse and HIV
针对药物滥用和艾滋病毒中的炎症小体
- 批准号:
10645136 - 财政年份:2020
- 资助金额:
$ 38.38万 - 项目类别:
Novel role of inflammasome activation in ART neurotoxicity
炎症小体激活在 ART 神经毒性中的新作用
- 批准号:
10163270 - 财政年份:2020
- 资助金额:
$ 38.38万 - 项目类别:
Targeting Inflammasomes in Substance Abuse and HIV
针对药物滥用和艾滋病毒中的炎症小体
- 批准号:
10371747 - 财政年份:2020
- 资助金额:
$ 38.38万 - 项目类别:
Targeting Inflammasomes in Substance Abuse and HIV
针对药物滥用和艾滋病毒中的炎症小体
- 批准号:
10622305 - 财政年份:2020
- 资助金额:
$ 38.38万 - 项目类别:
Targeting Inflammasomes in Substance Abuse and HIV
针对药物滥用和艾滋病毒中的炎症小体
- 批准号:
10404960 - 财政年份:2020
- 资助金额:
$ 38.38万 - 项目类别:
Novel role of inflammasome activation in ART neurotoxicity
炎症小体激活在 ART 神经毒性中的新作用
- 批准号:
9925422 - 财政年份:2020
- 资助金额:
$ 38.38万 - 项目类别:
相似海外基金
Digital cognitive-behavior therapy for anxiety and depressive disorders: Building an impactful research project from international partnerships and knowledge exchange in primary care
针对焦虑和抑郁症的数字认知行为疗法:通过初级保健领域的国际合作和知识交流建立一个有影响力的研究项目
- 批准号:
480808 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Miscellaneous Programs
Function of cost bias and effect of cognitive behavior therapy on social anxiety in children and adolescents
成本偏差的作用及认知行为治疗对儿童青少年社交焦虑的影响
- 批准号:
23K02970 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Combined Dialectical Behavior Therapy and Digital Cognitive Behavioral Therapy for Insomnia for Adolescents at High Risk for Suicide: A Pilot RCT
辩证行为疗法和数字认知行为疗法相结合治疗自杀高危青少年的失眠:一项试点随机对照试验
- 批准号:
10643478 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
A Randomized Clinical Trial Comparing Transdiagnostic Behavior Therapy to Disorder-Specific Psychotherapy in the Recovery of Veterans with Social Anxiety Disorder and Comorbid PTSD Symptomatology
一项随机临床试验,比较跨诊断行为疗法与特定障碍心理疗法在患有社交焦虑症和共病 PTSD 症状的退伍军人康复中的作用
- 批准号:
10746930 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Reducing suicide risk among aging caregivers of persons with AD/ADRD: Adapting, implementing, and evaluating Dialectical Behavior Therapy skills training interventions.
降低 AD/ADRD 患者老年护理人员的自杀风险:调整、实施和评估辩证行为治疗技能培训干预措施。
- 批准号:
10730708 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
A Randomized control trial of behavior therapy of tics in Japan. Exploring the behavior model of tics.
日本抽动行为治疗的随机对照试验。
- 批准号:
22K13840 - 财政年份:2022
- 资助金额:
$ 38.38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Role of Behavior Therapy Combined with Buprenorphine for the Treatment of Opioid Use Disorder
行为疗法联合丁丙诺啡治疗阿片类药物使用障碍的作用
- 批准号:
10440820 - 财政年份:2022
- 资助金额:
$ 38.38万 - 项目类别:
Efficacy of digital cognitive behavior therapy for insomnia for the prevention of perinatal depression
数字认知行为疗法治疗失眠预防围产期抑郁症的疗效
- 批准号:
10429841 - 财政年份:2022
- 资助金额:
$ 38.38万 - 项目类别:
Efficacy of digital cognitive behavior therapy for insomnia for the prevention of perinatal depression
数字认知行为疗法治疗失眠预防围产期抑郁症的疗效
- 批准号:
10656415 - 财政年份:2022
- 资助金额:
$ 38.38万 - 项目类别:
Efficacy of digital cognitive behavior therapy for insomnia for the prevention of perinatal depression - supplement
数字认知行为疗法治疗失眠预防围产期抑郁症的疗效 - 补充
- 批准号:
10794868 - 财政年份:2022
- 资助金额:
$ 38.38万 - 项目类别:














{{item.name}}会员




